Carl Zeiss Meditec AG (ETR:AFX)‘s stock had its “sell” rating reaffirmed by research analysts at DZ Bank AG in a research note issued to investors on Thursday.

Other equities research analysts have also recently issued research reports about the stock. Berenberg Bank set a €48.00 ($56.47) target price on shares of Carl Zeiss Meditec AG and gave the company a “buy” rating in a research report on Tuesday. Independent Research GmbH set a €44.00 ($51.76) target price on shares of Carl Zeiss Meditec AG and gave the company a “neutral” rating in a research report on Tuesday, August 15th. Commerzbank Ag set a €42.00 ($49.41) target price on shares of Carl Zeiss Meditec AG and gave the company a “neutral” rating in a research report on Tuesday, August 8th. Deutsche Bank AG set a €40.00 ($47.06) target price on shares of Carl Zeiss Meditec AG and gave the company a “neutral” rating in a research report on Tuesday, August 8th. Finally, Kepler Capital Markets set a €48.50 ($57.06) target price on shares of Carl Zeiss Meditec AG and gave the company a “buy” rating in a research report on Monday, August 7th. One analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of €45.75 ($53.82).

Shares of Carl Zeiss Meditec AG (ETR AFX) traded down 2.160% during mid-day trading on Thursday, reaching €44.889. 880 shares of the company’s stock were exchanged. The stock’s 50-day moving average is €43.49 and its 200-day moving average is €43.96. The stock has a market cap of €4.01 billion and a price-to-earnings ratio of 30.330. Carl Zeiss Meditec AG has a 52-week low of €30.80 and a 52-week high of €47.80.

COPYRIGHT VIOLATION NOTICE: “Carl Zeiss Meditec AG (AFX) Rating Reiterated by DZ Bank AG” was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another publication, it was stolen and reposted in violation of United States & international copyright laws. The original version of this news story can be accessed at https://www.americanbankingnews.com/2017/10/19/carl-zeiss-meditec-ag-afx-rating-reiterated-by-dz-bank-ag.html.

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company worldwide. It operates through Ophthalmic Devices and Microsurgery segments. The Ophthalmic Devices segment offers optical biometers, ophthalmic microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Analyst Recommendations for Carl Zeiss Meditec AG (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec AG and related companies with MarketBeat.com's FREE daily email newsletter.